Jonathan Rubin - SVP, Chief Medical Officer at Supernus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Medical Officer
Stock Symbol
SUPN on Nasdaq
All Insider Reports
All Insider Reports

Jonathan Rubin - trading volume in the past year for Supernus Pharmaceuticals, Inc.

Holdings reported by Jonathan Rubin for Supernus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 11K $509K $46.21 Sep 25, 2025 Direct
Restricted Stock Unit 2.5K $97.9K $39.15 Feb 23, 2025 Direct Common Stock
Performance Share Unit 0 $0 $35.59 Sep 25, 2025 Direct Common Stock
Performance Share Units 0 $0 $39.15 Feb 21, 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 20K Feb 19, 2025 Direct Common Stock

Transactions reported by Jonathan Rubin for Supernus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.